Diabetes Drug to be Evaluated for Chronic Heart Failure

Article

Two new outcome studies for Jardiance will be conducted in patients with type 2 diabetes.

Recently, Boehringer Ingelheim and Eli Lilly announced plans to conduct 2 additional outcome trials with the diabetes drug Jardiance within the next 12 months in patients with cardiovascular conditions. These new studies will build upon findings from the trial EMPA-REG OUTCOME.

EMPA-REG OUTCOME was a randomized, double-blind, placebo-controlled trial that included over 7000 patients with type 2 diabetes who also had a high risk for cardiovascular events.

The effect of Jardiance, along with glucose-lowering agents and cardiovascular drugs, such as blood pressure and cholesterol medication, were studied.

Researchers found that over a 3.1 year period, patients receiving Jardiance had a 14% reduction in non-fatal heart attack or non-fatal stroke compared with another group receiving a placebo.

Cardiovascular death was also reduced by 38%.

According to the study, Jardiance also reduced the risk of hospitalization for heart failure.

“The EMPA-REG OUTCOME trial demonstrated that JARDIANCE reduces the risk of cardiovascular death in diabetes patients at high CV risk, and we now look forward to exploring whether JARDIANCE can also provide heart failure benefits,” said Hans-Juergen Woerle, MD, global vice president medicine, Boehringer Ingelheim.

Related Videos
Pharmacist and Patient in Pharmacy | Image Credit: Gorodenkoff - stock.adobe.com
Catalyst Trial, Diabetes, Hypertension | Image Credit: grinny - stock.adobe.com
Various healthy foods -- Image credit: New Africa | stock.adobe.com
Ozempic, obesity, drug shortage, media portrayal | Image Credit: zimmytws - stock.adobe.com
Collaborative Care Team for Diabetes, Cardiovascular Disease | Image Credit: Production Perig - stock.adobe.com
Pharmacist helping patient use glucose monitor -- Image credit: Kalyakan | stock.adobe.com
Semaglutide Ozempic injection control blood sugar levels | Image Credit: myskin - stock.adobe.com
Semaglutide Ozempic injection control blood sugar levels | Image Credit: myskin - stock.adobe.com
Cholesterol diet and healthy food eating nutritional concept with clean fruits in nutritionist's heart dish and patient's blood sugar control record with diabetic measuring tool | Image Credit: Chinnapong - stock.adobe.com
© 2024 MJH Life Sciences

All rights reserved.